180 related articles for article (PubMed ID: 22890797)
1. Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer.
Mock JN; Costyn LJ; Wilding SL; Arnold RD; Cummings BS
Integr Biol (Camb); 2013 Jan; 5(1):172-82. PubMed ID: 22890797
[TBL] [Abstract][Full Text] [Related]
2. Liposomes Targeting P21 Activated Kinase-1 (PAK-1) and Selective for Secretory Phospholipase A
Najahi-Missaoui W; Quach ND; Somanath PR; Cummings BS
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321758
[TBL] [Abstract][Full Text] [Related]
3. Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells.
Quach ND; Mock JN; Scholpa NE; Eggert MW; Payré C; Lambeau G; Arnold RD; Cummings BS
Mol Pharm; 2014 Oct; 11(10):3443-51. PubMed ID: 25189995
[TBL] [Abstract][Full Text] [Related]
4. Sterically stabilized liposomes targeting P21 (RAC1) activated kinase-1 and secreted phospholipase A
Verma A; Najahi-Missaoui W; Cummings BS; Somanath PR
Oncol Lett; 2020 Nov; 20(5):179. PubMed ID: 32934746
[TBL] [Abstract][Full Text] [Related]
5. Secretory phospholipase A₂ responsive liposomes.
Zhu G; Mock JN; Aljuffali I; Cummings BS; Arnold RD
J Pharm Sci; 2011 Aug; 100(8):3146-3159. PubMed ID: 21455978
[TBL] [Abstract][Full Text] [Related]
6. Enhanced intracellular uptake of sterically stabilized liposomal Doxorubicin in vitro resulting in improved antitumor activity in vivo.
Xiong XB; Huang Y; Lu WL; Zhang H; Zhang X; Zhang Q
Pharm Res; 2005 Jun; 22(6):933-9. PubMed ID: 15948037
[TBL] [Abstract][Full Text] [Related]
7. Tissue distribution and therapeutic effect of intravenous free or encapsulated liposomal doxorubicin on human prostate carcinoma xenografts.
Vaage J; Barberá-Guillem E; Abra R; Huang A; Working P
Cancer; 1994 Mar; 73(5):1478-84. PubMed ID: 8111716
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of secretory phospholipases A2 in normal and malignant prostate cell lines: regulation by cytokines, cell signaling pathways, and epigenetic mechanisms.
Menschikowski M; Hagelgans A; Gussakovsky E; Kostka H; Paley EL; Siegert G
Neoplasia; 2008 Mar; 10(3):279-86. PubMed ID: 18320072
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, antitumor and cardioprotective effects of liposome-encapsulated phenylaminoethyl selenide in human prostate cancer rodent models.
Kang JY; Eggert M; Mouli S; Aljuffali I; Fu X; Nie B; Sheil A; Waddey K; Oldham CD; May SW; Amin R; Arnold RD
Pharm Res; 2015 Mar; 32(3):852-62. PubMed ID: 25158648
[TBL] [Abstract][Full Text] [Related]
10. Liposomes containing alkylated methotrexate analogues for phospholipase A(2) mediated tumor targeted drug delivery.
Kaasgaard T; Andresen TL; Jensen SS; Holte RO; Jensen LT; Jørgensen K
Chem Phys Lipids; 2009 Feb; 157(2):94-103. PubMed ID: 19094974
[TBL] [Abstract][Full Text] [Related]
11. Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo.
Xiong XB; Huang Y; Lu WL; Zhang X; Zhang H; Nagai T; Zhang Q
J Pharm Sci; 2005 Aug; 94(8):1782-93. PubMed ID: 15986461
[TBL] [Abstract][Full Text] [Related]
12. Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic.
Xiong XB; Huang Y; Lu WL; Zhang X; Zhang H; Nagai T; Zhang Q
J Control Release; 2005 Oct; 107(2):262-75. PubMed ID: 16125816
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-Guided Delivery of siRNA and a Chemotherapeutic Drug by Using Microbubble Complexes: In Vitro and In Vivo Evaluations in a Prostate Cancer Model.
Bae YJ; Yoon YI; Yoon TJ; Lee HJ
Korean J Radiol; 2016; 17(4):497-508. PubMed ID: 27390541
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic action of secreted phospholipase A2 in prostate cancer.
Sved P; Scott KF; McLeod D; King NJ; Singh J; Tsatralis T; Nikolov B; Boulas J; Nallan L; Gelb MH; Sajinovic M; Graham GG; Russell PJ; Dong Q
Cancer Res; 2004 Oct; 64(19):6934-40. PubMed ID: 15466184
[TBL] [Abstract][Full Text] [Related]
15. RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer.
Zhao H; Wang JC; Sun QS; Luo CL; Zhang Q
J Drug Target; 2009 Jan; 17(1):10-8. PubMed ID: 19016068
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic study of the sPLA2-mediated hydrolysis of a thio-ester pro anticancer ether lipid.
Linderoth L; Fristrup P; Hansen M; Melander F; Madsen R; Andresen TL; Peters GH
J Am Chem Soc; 2009 Sep; 131(34):12193-200. PubMed ID: 19663381
[TBL] [Abstract][Full Text] [Related]
17. Genistein, a potent inhibitor of secretory phospholipase A2: a new insight in down regulation of inflammation.
Dharmappa KK; Mohamed R; Shivaprasad HV; Vishwanath BS
Inflammopharmacology; 2010 Feb; 18(1):25-31. PubMed ID: 19894024
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo Evaluation of a Novel Estrogen-Targeted PEGylated Oxaliplatin Liposome for Gastric Cancer.
Sun Y; Xie Y; Tang H; Ren Z; Luan X; Zhang Y; Zhu M; Lv Z; Bao H; Li Y; Liu R; Shen Y; Zheng Y; Pei J
Int J Nanomedicine; 2021; 16():8279-8303. PubMed ID: 34992365
[TBL] [Abstract][Full Text] [Related]
19. PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer.
Xiang B; Dong DW; Shi NQ; Gao W; Yang ZZ; Cui Y; Cao DY; Qi XR
Biomaterials; 2013 Sep; 34(28):6976-91. PubMed ID: 23777916
[TBL] [Abstract][Full Text] [Related]
20. iNGR-Modified Liposomes for Tumor Vascular Targeting and Tumor Tissue Penetrating Delivery in the Treatment of Glioblastoma.
Zhou JE; Yu J; Gao L; Sun L; Peng T; Wang J; Zhu J; Lu W; Zhang L; Yan Z; Yu L
Mol Pharm; 2017 May; 14(5):1811-1820. PubMed ID: 28388081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]